^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    VAC2

    i
    Other names: AST-VAC2, VAC2
    Associations

    News

    Trials
    Company:
    Cancer Research UK, Lineage Cell Therap
    Drug class:
    Immunostimulant, Telomerase inhibitor
    Related drugs:
    Associations

    News

    Trials
    1year
    CRUKD/17/003: AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer (clinicaltrials.gov)
    P1, N=9, Completed, Cancer Research UK | Active, not recruiting --> Completed | Trial completion date: Feb 2027 --> Aug 2022 | Trial primary completion date: Feb 2027 --> Aug 2022
    Trial completion • Trial completion date • Trial primary completion date • Metastases
    |
    TERT (Telomerase Reverse Transcriptase)
    |
    VAC2